NCT03761069 2022-02-02
Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias
PTC Therapeutics
Phase 1 Terminated
Clinical Trials
5 trialsNCT00911248 2019-04-12
PTC299 for Treatment of Neurofibromatosis Type 2
PTC Therapeutics
Phase 2 Terminated
NCT00686842 2018-06-06
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 1/2 Terminated
NCT00508586 2016-03-03
PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer
PTC Therapeutics
Phase 1 Completed
NCT01158300 2015-05-04
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
Pediatric Brain Tumor Consortium
Phase 1 Completed